CURRENT ADVANCES IN CLINICAL ONCOLOGY: CHALLENGES AND FUTURE PERSPECTIVES
TL;DR
The continued integration of genomics, AI-driven diagnostics, biomarker-guided therapies, and multidisciplinary clinical approaches is anticipated to improve patient outcomes while promoting precision oncology as the new standard of cancer care.
Abstract
Cancer remains one of the leading causes of morbidity and mortality worldwide despite remarkable advances in prevention, diagnosis, and treatment. The rapid development of molecular biology, precision medicine, immunotherapy, artificial intelligence, and genomic technologies has transformed the landscape of modern oncology, enabling more individualized and effective patient care. Recent breakthroughs in liquid biopsy, next-generation sequencing, targeted therapies, immune checkpoint inhibitors, and AI-assisted clinical decision-making have significantly improved diagnostic accuracy, therapeutic efficacy, and survival outcomes across multiple cancer types. However, numerous challenges persist, including tumor heterogeneity, treatment resistance, immune-related adverse events, limited accessibility to innovative therapies, high healthcare costs, and disparities in cancer care across different regions. Furthermore, integrating multi-omics technologies, digital pathology, and real-world evidence into routine clinical practice requires standardized protocols and robust clinical validation. This review summarizes the most significant advances in contemporary clinical oncology, discusses current limitations affecting cancer management, and highlights emerging technologies that are expected to shape the future of personalized cancer treatment. The continued integration of genomics, AI-driven diagnostics, biomarker-guided therapies, and multidisciplinary clinical approaches is anticipated to improve patient outcomes while promoting precision oncology as the new standard of cancer care.